Collaboration with trial investigators, supervisory bodies, study groups and research-based drug manufacturers is vital for the success of our clinical trials.
A comprehensive stakeholder network is the key to success
With around 500 study centers and more than 1,000 trial investigators in Germany, we have a strong scientific network. We also collaborate with numerous other national and international study groups as well as leading drug manufacturers and biotech companies.
Continuous monitoring of study data
An “Independent Data and Safety Monitoring Committee” (IDMC) monitors the study data and ensures that the studies are conducted in accordance with the regulatory requirements. The IDMC consists of highly experienced experts in clinical research who review all accumulated study data twice a year.
The IDMC assesses potential safety or ethical concerns over the course of our studies.
Worldwide collaboration for new treatment options
The implementation of international multicenter studies requires close collaboration with other national and international study groups. We are a key player in this global scientific network of clinical breast cancer researchers.
Nowadays, basic research methods are so complex that no single organization has the in-house capability to handle all the disciplines involved. International collaboration pooling the expertise of multiple partner organizations is the key to success.
Ultimately, successful collaboration produces results that could not be achieved by any one organization alone, thus furthering progress and benefiting all parties involved, above all patients.
The following are just a few of our many partners:
- ABCSG: Austrian Breast & Colorectal Cancer Study Group
- AGO-B: Breast Study Group
- BIG: Breast International Group
- BOOG: Borstkanker Onderzoek Groep (Niederlande)
- CECOG: Central European Cooperative Oncology Group
- CRUK: Cancer Research UK
- CTRU: Clinical Trials Research Unit
- DKG: Deutsche Krebsgesellschaft
- GEICAM: Grupo Español de Investigación en Cáncer de Mama
- IBCSG: International Breast Cancer Study Group
- ICCG: International Collaborative Cancer Group
- JBCRG Japan Breast Cancer Research Group
- NOGGO: Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie
- NSABP: National Breast and Bowel Project
- SBG: Scandinavian Breast Group
- SOLTI: Grupo Español de Estudio, Tratamiento y otras Estrategias Experimentales en Tumores Sólidos
- UNICANCER Group
- UZL: University Hospitals of Leuven
In addition, we are a member of the ‘Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V. (TMF)’ (Technology and Methods Platform for Networked Medical Research).
